Natera Shares Rise 2.4% After Announcing ctDNA Detection Advance
Natera said incorporating phased and structural variants enables ctDNA detection significantly below 1 part per 10 million, elevating molecular residual disease sensitivity.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.